Moderna Soars 177% as Melanoma Vaccine Breakthrough Boosts Merck Posted on August 20, 2026 by http://wealthcreation.club ‼️ 🧬 Moderna surged 177% and Merck gained 12% after their late-stage melanoma vaccine trial showed the combination therapy significantly prolonged recurrence-free survival versus Keytruda alone and lowered the risk of distant metastasis. Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Like Loading... Published by http://wealthcreation.club http://wealthcreation.club—We are educating regular people about how to be able to make more money in a disciplined way View all posts by http://wealthcreation.club
AlgoTrader 